GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (LSE:GDR) » Definitions » Construction In Progress

Genedrive (LSE:GDR) Construction In Progress : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Genedrive Construction In Progress?


Genedrive Construction In Progress Historical Data

The historical data trend for Genedrive's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Construction In Progress Chart

Genedrive Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genedrive Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genedrive Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Genedrive (LSE:GDR) Business Description

Traded in Other Exchanges
Address
48 Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Genedrive (LSE:GDR) Headlines

No Headlines